Potchefstroom is now home to South Africa’s premier bariatric weight loss surgery facility, with Dr. Mpho Sandamela and Lenmed Mooimed Private Hospital receiving accreditation from the South African Metabolic Medicine and Surgery Society (SAMMSS). This prestigious accreditation confirms the hospital’s adherence to the highest standards of surgical excellence, patient safety, and positive clinical outcomes, making it the first and only SAMMSS-accredited bariatric unit in the North-West.
Dr. Mpho Sandamela, a skilled specialist surgeon born in the Vaal Triangle, brings extensive international experience to Potchefstroom. After studying at the University of Pretoria, he worked as a Resident Medical Officer in the UK and later as a Family Physician in Canada before relocating to Potchefstroom in 2021. His practice also includes a Varicose Veins treatment clinic and an Endoscopic Suite for gastroscopies and colonoscopies, ensuring a comprehensive healthcare offering.
With the backing of a multidisciplinary team, Dr. Sandamela provides a holistic weight loss journey, assisting patients with medical aid authorizations and personalised care plans. The team also includes specialist physicians, psychologists, physiotherapists, social workers, and dietitians, all dedicated to supporting patients in achieving long-term weight loss success.
Lenmed Mooimed Private Hospital’s bariatric unit now offers state-of-the-art laparoscopic and minimally invasive surgical techniques, ensuring a safer, more effective approach to weight loss surgery. Bariatric surgery can help address obesity-related conditions such as Type 2 diabetes, hypertension, joint pain, and sleep apnea, offering significant improvements in quality of life.
Dr. Sandamela is clear about the philosophy of his practice: “Being obese is not your fault, but achieving and maintaining a healthy lifestyle is your responsibility. We are here to help you with that.”
To qualify for weight loss surgery, patients must have a BMI of 35 or higher, or a BMI between 30-34.9 with one obesity-related condition.
Related Topics:
Long-Term Impact of GLP-1 Weight-Loss Drugs on Children and Teens Still Unclear
